People · Operator
Named in public records as an officer, director or promoter · active 2014–2022 · Healthtech, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Autonomous Medical Devices Inc | — | Healthtech | Series D+ | $142.4M | $2.8B | 2016 |
| Neotx Holdings Ltd. | — | Biotechnology | Series C | $93.9M | $907.5M | 2022 |
| Cocrystal Pharma, Inc. | — | Pharmaceuticals | Series A | $28.9M | $92.9M | 2014 |
| Xenetic Biosciences, Inc. | — | Biotechnology | Series A | $17.6M | $5.9M | 2019 |
Roger Kornberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roger Kornberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Marinelli | 2 | 4 |
| Steven D. Rubin | 1 | 9 |
| Steven Rubin | 1 | 7 |
| Josh Shachar | 1 | 5 |
| Frank Adell | 1 | 5 |
| Thomas Chen | 1 | 5 |
| JANE H HSIAO | 1 | 5 |
| Sam Lee | 1 | 5 |
| Gary Wilcox | 1 | 4 |
| David Okrongly | 1 | 4 |
| Jeffrey Eisenberg | 1 | 4 |
| Raymond F. Schinazi | 1 | 4 |
| Jane Hsiao | 1 | 3 |
| Phillip Frost | 1 | 3 |
| Curtis Lockshin | 1 | 3 |
| JEFFREY A MECKLER | 1 | 3 |
| J. Tomilson Hill | 1 | 3 |
| Grigory Borisenko | 1 | 3 |
| Jeremy Ruskin | 1 | 2 |
| James Parslow | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.